You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Non-small cell lung cancer (NSCLC)

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Non Small Cell Lung Cancer Trial ([18F]F-AraG)

Not yet recruiting
  • Advanced Non Small Cell Lung Cancer
  • (no location specified)
Oct 24, 2023

Non-small Cell Lung Carcinoma Trial (BPI-361175)

Not yet recruiting
  • Non-small Cell Lung Carcinoma
  • (no location specified)
Oct 18, 2022

Non Small Cell Lung Cancer Trial in Leiden, Rotterdam (TEIPP24 (LRPAP7-30V-SLP vaccine in Montanide ISA-51))

Recruiting
  • Non Small Cell Lung Cancer
  • TEIPP24 (LRPAP7-30V-SLP vaccine in Montanide ISA-51)
  • Leiden, Zuid-Holland, Netherlands
  • +1 more
Jun 1, 2023

NSCLC (Non-small-cell Lung Cancer) Trial in Changchun (Sintilimab, IBI310)

Recruiting
  • NSCLC (Non-small-cell Lung Cancer)
  • Changchun, Jilin, China
    The First Hospital of Jilin University
Sep 21, 2022

Locally Advanced or Metastatic NSCLC Trial (HB1801, Taxotere)

Not yet recruiting
  • Locally Advanced or Metastatic Non-Small Cell Lung Cancer
  • (no location specified)
May 8, 2023

Lung Cancer, Nonsmall Cell, Lung Cancer Stage III Trial (combination product, drug, procedure, radiation)

Not yet recruiting
  • Lung Cancer, Nonsmall Cell
  • Lung Cancer Stage III
  • Nivolumab and Chemotherapy
  • +3 more
  • (no location specified)
Aug 15, 2023

NSCLC Stage IV Trial (HLX26, Serplulimab, Pemetrexed)

Not yet recruiting
  • NSCLC Stage IV
  • (no location specified)
Mar 15, 2023

Results of Specific Gene Testing and Efficacy of Targeted

Completed
  • Non Small Cell Lung Cancer
    • Changsha, Hunan, China
      Hunan Cancer hospital
    Mar 27, 2023

    NSCLC Trial (Anlotinib Hydrochloride, penpulimab, SBRT)

    Not yet recruiting
    • Non-Small Cell Lung Cancer
    • Anlotinib Hydrochloride
    • +2 more
    • (no location specified)
    Aug 2, 2022

    NSCLC Trial in Guangzhou (BL-M07D1)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Nov 1, 2023

    NSCLC Trial in Jette (68GaNOTA-Anti-MMR-VHH2)

    Recruiting
    • Non-small Cell Lung Cancer
    • Jette, Brussel, Belgium
      Universitair Ziekenhuis Brussel
    Jun 27, 2023

    NSCLC Trial (Amivantamab, Lazertinib, Doxycycline)

    Not yet recruiting
    • Carcinoma, Non-Small-Cell Lung
    • (no location specified)
    Nov 7, 2023

    Non Small Cell Lung Cancer Trial in Beijing (DZD9008)

    Recruiting
    • Non Small Cell Lung Cancer
    • Beijing, Beijing, China
      Department of Respiratory and Critical Care Medicine, Peking Uni
    Sep 24, 2022

    NSCLC Stage IV, NSCLC Stage IIIB, NSCLC Stage IIIC Trial in China (Cadonilimab, Anlotinib, Docetaxel)

    Recruiting
    • NSCLC Stage IV
    • +2 more
    • Hefei, Anhui, China
    • +4 more
    Apr 15, 2023

    Efficacy and Safety of Anlotinib for Advanced Non-small Cell

    Completed
    • NSCLC
      • Wuhan, Hubei, China
        Hubei province
      Oct 19, 2022

      NSCLC Trial in Iowa City ([18F]F-ARAG PET)

      Not yet recruiting
      • Non-small Cell Lung Cancer
      • [18F]F-ARAG PET
      • Iowa City, Iowa
        University of Iowa Hospitals and Clinics
      Oct 10, 2023

      NSCLC Trial in Shanghai (SI-B001, SI-B003)

      Not yet recruiting
      • Non-small Cell Lung Cancer
      • Shanghai, Shanghai, China
        Shanghai Pulmonary Hospital
      Jul 10, 2023

      NSCLC Trial in Shanghai (SBRT+LDRT, Toripalimab, Chemotherapy drug)

      Recruiting
      • NSCLC
      • SBRT+LDRT
      • +2 more
      • Shanghai, Shanghai, China
        Shanghai Chest Hospital
      Apr 2, 2023

      NSCLC (NSCLC) Trial (Osimertinib, Amivantamab)

      Not yet recruiting
      • Non-Small Cell Lung Cancer (NSCLC)
      • (no location specified)
      Mar 24, 2023

      NSCLC Trial in Guangzhou (SKB264, Pembrolizumab, Carboplatin)

      Not yet recruiting
      • Non-small Cell Lung Cancer
      • Guangzhou, Guangdong, China
        Sun Yat-sen University, Cancer Center
      Apr 14, 2023

      NSCLC (NSCLC) Trial in Switzerland (Lifestyle)

      Not yet recruiting
      • Non-Small Cell Lung Cancer (NSCLC)
      • Lifestyle
      • Barmelweid, Switzerland
      • +3 more
      Apr 25, 2023

      Lung Cancer, Non Small Cell Lung Cancer, Adenocarcinoma of Lung Trial run by the National Cancer Institute (NCI) (LMB-100,

      Active, not recruiting
      • Lung Cancer
      • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Oct 4, 2022

      NSCLC, NSCLC, Nonsmall Cell Lung Cancer Trial in Saint Louis (Nintedanib)

      Active, not recruiting
      Has Results
      • Carcinoma, Non-Small-Cell Lung
      • +2 more
      • Saint Louis, Missouri
        Washington University School of Medicine
      Jan 3, 2023

      NSCLC, NSCLC Trial in Bronx (PembroRT, ChemoRT)

      Active, not recruiting
      • Non-small Cell Lung Cancer, NSCLC
      • Bronx, New York
        Montefiore Medical Center
      Dec 6, 2022

      d To Treat People With Non-Small Cell Lung Cancer

      Recruiting
      • Non-small Cell Lung Cancer (NSCLC)
      • Tokyo, Japan
        Takeda Selected Site
      Oct 13, 2022